MaxCyte Stock

MaxCyte Dividend

Delisted

Dividend of MaxCyte (MXCT) as of Jul 24, 2026.

Dividend

0.00USD

Last updated:

How much dividend does MaxCyte 2026 pay?

According to the latest status from July 2026, MaxCyte paid a total of 0.00 USD per share in dividends within the last 12 months. With the current MaxCyte price of 0.01 USD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical MaxCyte Dividends

PaydateDividend

Is the MaxCyte Dividend Safe?

MaxCyte has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding MaxCyte's Dividend Distributions

MaxCyte’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining MaxCyte's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

MaxCyte's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in MaxCyte’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

MaxCyte Stock analysis

What does MaxCyte do? MaxCyte Inc is a US biotechnology company specializing in the development of platform-based technologies for the next generation of gene and cell therapies. They offer integrated platform technology for drug manufacturing, research, and development. Their proprietary platform technology, Flow ElectroporationTM, allows for efficient transduction of a variety of cells, making it a valuable tool for the production of CAR-T cell therapies. They also offer services for lentiviral production and customized gene therapy production. MaxCyte has secured $50 million in funding for expansion and has formed important partnerships in the industry. They are a leading player in the development of innovative technologies for gene and cell therapy products. MaxCyte is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MaxCyte stock

MaxCyte paid dividends every year for the past 0 years.

Dividend calendar 2026
Access this data via the Eulerpool API
Get Free API Key

All Key Metrics — MaxCyte